
Photo: Depositphotos
Apr 9, 2025, 07:20
MPN Advocacy – Practical guidance on transitioning patients to ropeginterferon alfa-2b
MPN Advocacy posted on LinkedIn:
“Thank you to Ruben Mesa, Abdulraheem Yacoub, Tsewang Tashi, Wanxing Chai-Ho, Chang Ho Yoon, and John Mascarenhas for creating this dialogue with the peginterferon Alfa-2a shortages that are impacting MPN patients worldwide.”
“Navigating the peginterferon Alfa-2a shortage: practical guidance on transitioning patients to ropeginterferon alfa-2b.”
Authors: Ruben Mesa, Abdulraheem Yacoub, Tsewang Tashi, Wanxing Chai-Ho, Chang Ho Yoon, and John Mascarenhas
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 15, 2025, 12:02
Apr 15, 2025, 11:54
Apr 15, 2025, 11:52